Cargando…
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States
Data from REVEAL (Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices; n = 2309), the first study of its kind, confirm that many patients experience quality of life and work productivity impairments that might negatively affect their lives. In the future, long...
Autores principales: | Mesa, Ruben, Boccia, Ralph V., Grunwald, Michael R., Oh, Stephen T., Colucci, Philomena, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148983/ https://www.ncbi.nlm.nih.gov/pubmed/30122202 http://dx.doi.org/10.1016/j.clml.2018.05.020 |
Ejemplares similares
-
Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States
por: Grunwald, Michael R., et al.
Publicado: (2018) -
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study
por: Grunwald, Michael R., et al.
Publicado: (2019) -
Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data
por: Paranagama, Dilan, et al.
Publicado: (2018) -
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study
por: Grunwald, Michael R., et al.
Publicado: (2020) -
Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study
por: Zwicker, Jeffrey I., et al.
Publicado: (2021)